Multidrug-Resistant Organism Infections in US Nursing Homes: A National Study of Prevalence, Onset, and Transmission across Care Settings, October 1, 2010-December 31, 2011
- 1 October 2014
- journal article
- Published by Cambridge University Press (CUP) in Infection Control & Hospital Epidemiology
- Vol. 35 (S3), S48-S55
- https://doi.org/10.1086/677835
Abstract
Objective.To understand the prevalence of multidrug-resistant organism (MDRO) infections among nursing home (NH) residents and the potential for their spread between NHs and acute care hospitals (ACHs).Methods.Descriptive analyses of MDRO infections among NH residents using all NH residents in the Long-Term Care Minimum Data Set (MDS) 3.0 between October 1, 2010 and December 31, 2011.Results.Analysis of MDS data revealed a very high volume of bidirectional patient flow between NHs and ACHs, indicating the need to study MDRO infections in NHs as well as in hospitals. A total of 4.24% of NH residents had an active MDRO diagnosis on at least 1 MDS assessment during the study period. This rate significantly varied by sex, age, urban/rural status, and state. Approximately 2% of NH discharges to ACHs involved a resident with an active diagnosis of infection due to MDROs. Conversely, 1.8% of NH admissions from an ACH involved a patient with an active diagnosis of infection due to MDROs. Among residents who acquired an MDRO infection during the study period, 57% became positive in the NH, 41% in the ACH, and 2% in other settings (eg, at a private home or apartment).Conclusion.Even though NHs are the most likely setting where residents would acquire MDROs after admission to an NH (accounting for 57% of cases), a significant fraction of NH residents acquire MDRO infection at ACHs (41%). Thus, effective MDRO infection control for NH residents requires simultaneous, cooperative interventions among NHs and ACHs in the same community.Keywords
This publication has 24 references indexed in Scilit:
- The Emerging Threat of Multidrug-Resistant Gram-Negative Organisms in Long-Term Care FacilitiesThe Journals of Gerontology: Series A, 2009
- Bad Bugs, No Drugs: No ESKAPE! An Update from the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2009
- SHEA/APIC Guideline: Infection prevention and control in the long-term care facilityAmerican Journal of Infection Control, 2008
- Multidrug‐Resistant Gram‐Negative Bacteria in a Long‐Term Care Facility: Prevalence and Risk FactorsJournal of the American Geriatrics Society, 2008
- Management of multidrug-resistant organisms in health care settings, 2006American Journal of Infection Control, 2007
- The Clinical Impact of Multiresistant Gram-Positive Microorganisms in Long-Term Care FacilitiesJournal of the American Medical Directors Association, 2003
- Natural History of Colonization With Vancomycin-Resistant Enterococci, Methicillin-Resistant Staphylococcus Aureus, And Resistant Gram-Negative Bacilli Among Long-Term–Care Facility ResidentsInfection Control & Hospital Epidemiology, 2003
- Methicillin-resistant Staphylococcus aureus:: Long-term care concernsAmerican Journal Of Medicine, 1999
- Issues in the Management of Resistant Bacteria in Long-Term–Care FacilitiesInfection Control & Hospital Epidemiology, 1999
- Antimicrobial Resistance in Long-Term-Care FacilitiesInfection Control & Hospital Epidemiology, 1996